B. Sommer

Cell Viability, Measurement

Ning Wei, B. Sommer, 2010 .

Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins.

K. Friehs, E. Flaschel, B. Sommer, 2010, Journal of biotechnology.

Extracellular production and affinity purification of recombinant proteins with Escherichia coli using the versatility of the maltose binding protein.

T. Scheper, K. Friehs, F. Stahl, 2009, Journal of biotechnology.

TRAF5 Deficiency Accelerates Atherogenesis in Mice by Increasing Inflammatory Cell Recruitment and Foam Cell Formation

C. Bode, H. Nakano, A. Zirlik, 2010, Circulation research.

Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies

E. Oakeley, Sandrine Romand, Laetitia Malphettes, 2018, BMC Proceedings.

Enabling low cost biopharmaceuticals: high level interferon alpha-2b production in Trichoderma reesei

B. Helk, Ramon Wahl, M. Saloheimo, 2016, Microbial Cell Factories.

Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall

P. Libby, C. Bode, A. Zirlik, 2010, Circulation.

Degradation of recombinant proteins by Chinese hamster ovary host cell proteases is prevented by matriptase‐1 knockout

E. Oakeley, Sandrine Romand, Holger Laux, 2018, Biotechnology and bioengineering.